Sygnis SA (WSE:SYG)
1.300
+0.030 (2.36%)
Last updated: Jul 3, 2026, 1:15 PM CET
Sygnis Market Cap
Sygnis has a market cap or net worth of 42.42 million as of July 6, 2026. Its market cap has increased by 66.38% in one year.
Market Cap
42.42M
Enterprise Value
45.13M
Revenue
11.33M
Ranking
n/a
PE Ratio
104.94
Stock Price
1.30
Market Cap Chart
Since March 16, 2012, Sygnis's market cap has increased from 6.21M to 42.42M, an increase of 583.22%. That is a compound annual growth rate of 14.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2026 | 42.42M | -28.40% |
| Dec 30, 2025 | 59.24M | 501.78% |
| Dec 30, 2024 | 9.84M | -56.47% |
| Dec 29, 2023 | 22.62M | -56.95% |
| Dec 30, 2022 | 52.54M | 10.53% |
| Dec 30, 2021 | 47.53M | 177.19% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 6.06B |
| NEUCA | 3.19B |
| Synektik Spólka Akcyjna | 2.98B |
| Voxel | 1.21B |
| Read-Gene | 58.24M |
| Milton Essex Spólka Akcyjna | 49.35M |
| Nestmedic | 40.83M |
| BioMaxima | 39.83M |